Development of a trial application to assess the effectiveness and cost-effectiveness of adult dRug scrEening and brief interventionS in key hEalth, social care and justice setTings: The RESET PROJECT

<ns3:p>Background In England and Wales, alcohol-related crime is estimated to cost society £27.4 billion and drugs £20 billion annually. Effective interventions therefore have the potential to reduce the costs relating to substance use and increase individual social welfare. Brief drug use interventions are a secondary prevention activity, which are aimed at those individuals who are using substances in a pattern that is likely to be harmful to health and/or well-being. At present there is limited evidence regarding the effects and most of the work has been carried out outside the UK. We examined the evidence to develop a trial to test effectiveness of brief drug interventions. Methods We carried out two systematic reviews of the literature and examined effectiveness, barriers and facilitators, screening tools and active ingredients of interventions. We also carried out qualitative work to examine this issue. Results The quantitative review included 46 papers (mostly from the USA) and the qualitative review included 14. We ascertained that the ASSIST screening tool was the best tool to use for screening . We carried out interviews with practitioners, policy makers and individuals who have had experience of mental health, criminal justice and family services which were identified as the services we should work with for a definitive trial. Key issues community members perceived included the need to address trauma, the efficacy of interventions, how stigma and societal views affect individuals, the importance of support from various institutions, and how community involvement and personal responsibility play a role in the recovery process.Stakeholders emphasised the need for interventions to be brief yet personalised, underlining the importance of trust and effective evaluation. Conclusions We used the findings from the reviews and qualitative work to develop a robust pilot trial application.</ns3:p>